Ecolab (ECL) Q3 2025 Earnings
How Did ECL Stock React to Q3 2025 Earnings?
S&P 500 over the same 30 days: −0.53%.
Did ECL Beat Earnings? Q3 2025 Results
No. Ecolab reported Q3 2025 earnings of $2.07 a share on Oct 28, 2025, missing the $2.07 consensus estimate by 0.1%. Revenue was $4.2B against a $4.1B estimate.
Ecolab posted a broadly solid third quarter for fiscal 2025, with revenue clearing expectations even as adjusted earnings came in just a hair below the consensus. The water, hygiene, and infection prevention giant reported Q3 revenue of $4.17 billion, up 4.2% year-over-year and ahead of the $4.12 billion analysts had forecast, while adjusted diluted EPS of $2.07 landed fractionally below the $2.07 consensus estimate, a miss of just 0.09%. The headline earnings comparison looked stark on a reported basis, as the prior-year period included a $364 million gain from the divestiture of the global surgical solutions business, but the underlying story was one of consistent execution: organic sales grew 3%, driven by accelerating value pricing and steady volume gains, while organic operating income margin expanded 110 basis points to 18.7%. Growth engines including Life Sciences, Pest Elimination, and Ecolab Digital, which grew sales 25% to $96 million, continued to lead. Despite a post-earnings share pullback, management tightened full-year 2025 adjusted EPS guidance to $7.48 to $7.58, representing 12% to 14% growth, and expressed confidence in sustaining 12% to 15% EPS growth into 2026.
- Value pricing accelerating from 2% to 3%
- Continued 1% volume growth driven by new business wins and breakthrough innovation
- Strong organic operating income margin expansion of 110 bps to 18.7%
- Growth engines (Life Sciences, Pest Elimination, Global High-Tech, Ecolab Digital) collectively grew double digits
- Improved supply chain operations and productivity
- One Ecolab enterprise growth strategy driving cross-selling
“Our team once again delivered a strong and consistent quarter of double-digit earnings growth, driven by value pricing accelerating from 2% to 3%, volume growth of 1%, and strong operating income margin expansion. Ecolab's growth engines, which include Life Sciences, Pest Elimination, Global High-Tech and Ecolab Digital, collectively grew double digits. Performance in our core businesses was led by mid-single digit growth in Institutional & Specialty and accelerating Food & Beverage growth, as we leveraged our breakthrough innovations and the power of our One Ecolab enterprise growth strategy.”
Ecolab CEO, on the earnings call
What Was Ecolab's Outlook in Q3 2025?
Ecolab sharpened its full-year 2025 adjusted diluted EPS guidance to $7.48–$7.58, representing 12%–14% growth versus 2024's $6.65. Fourth quarter 2025 adjusted diluted EPS is expected in the $2.02–$2.12 range, up 12%–17% year-over-year. Management expressed confidence in delivering 12%–15% EPS growth in 2026 beginning in Q1. Secular growth trends in water, hygiene, infection prevention, and digital technologies continue to fuel long-term demand. Near-term risks include unpredictable geopolitics and evolving trade policy impacting end-market demand. The company expects approximately $0.34 per share of special charges in 2025 related to restructuring.
ECL YoY Financials
| Metric | Q3 2025 | Q3 2024 | Year over year |
|---|---|---|---|
| Revenue | $4.2B | $4.0B | +4.2% |
| Gross Profit | $1.9B | $1.7B | +7.5% |
| Operating Income | $760.2M | $707.2M | +7.5% |
| Net Income | $585.0M | $736.5M | −20.6% |
ECL Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.